{
    "clinical_study": {
        "@rank": "30305", 
        "brief_summary": {
            "textblock": "PRIMARY: To determine the effect of 8 weeks of zidovudine (AZT) treatment on the HIV-1\n      burden in peripheral blood and lymphoid tissue in HIV-1-infected, AZT-naive patients with\n      CD4+ T lymphocyte counts between 100 and 500 cells/mm3.\n\n      SECONDARY: To determine the extent to which apoptosis (programmed cell death) occurs in\n      these patients.\n\n      In previous trials of AZT treatment in HIV-infected patients, an antiviral effect has been\n      clearly demonstrated by quantitative measurement of virus in plasma and peripheral blood\n      mononuclear cells. However, the lymphoid tissues appear to be a major reservoir for HIV-1\n      and a major site of virus replication in HIV-infected persons. Further data is needed to\n      assess the effect of treatment on viral burden and HIV-1 replication in lymphoid tissue."
        }, 
        "brief_title": "Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "In previous trials of AZT treatment in HIV-infected patients, an antiviral effect has been\n      clearly demonstrated by quantitative measurement of virus in plasma and peripheral blood\n      mononuclear cells. However, the lymphoid tissues appear to be a major reservoir for HIV-1\n      and a major site of virus replication in HIV-infected persons. Further data is needed to\n      assess the effect of treatment on viral burden and HIV-1 replication in lymphoid tissue.\n\n      Patients receive AZT daily for 8 weeks and are followed in clinic at weeks 2, 4, 6, 8, 9,\n      and 14 (or possibly via telephone call at week 14). Patients undergo a lymph node biopsy at\n      day 0 and week 8."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Prophylaxis against AIDS-related opportunistic infections.\n\n          -  Supportive therapies, such as medications for nausea, vomiting, anemia, and\n             analgesia.\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  CD4 count 100 - 500 cells/mm3.\n\n          -  At least two palpable lymph nodes.\n\n          -  Plasma viremia.\n\n          -  No CURRENT AIDS-defining conditions.\n\n          -  No prior antiretroviral treatment.\n\n        Exclusion Criteria\n\n        Concurrent Medication:\n\n        Excluded during the first 8 weeks of study:\n\n          -  Other antiretroviral agents.\n\n          -  Steroids.\n\n          -  Interleukins.\n\n          -  Interferons.\n\n          -  Cytotoxic chemotherapy.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Prior antiretroviral therapy.\n\n          -  Prior cytotoxic chemotherapy.\n\n          -  Acute therapy for an infection or another medical illness within 14 days prior to\n             study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "18", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000818", 
            "org_study_id": "DATRI 012"
        }, 
        "intervention": {
            "intervention_name": "Zidovudine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Zidovudine"
        }, 
        "keyword": [
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Zidovudine", 
            "Lymph Nodes", 
            "Lymphoid Tissue"
        ], 
        "lastchanged_date": "July 28, 2008", 
        "link": {
            "description": "Click here for more information about Zidovudine", 
            "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=4"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048"
                    }, 
                    "name": "Cedars Sinai Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palo Alto", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94304"
                    }, 
                    "name": "Palo Alto Veterans Affairs Health Care System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Redwood City", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94063"
                    }, 
                    "name": "AIDS Community Research Consortium"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115"
                    }, 
                    "name": "Mount Zion Med Ctr / UCSF"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33316"
                    }, 
                    "name": "North Broward Hosp District"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maitland", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32751"
                    }, 
                    "name": "Goodgame Med Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Univ of Illinois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Univ of Texas Southwestern Med Ctr of Dallas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Baylor College of Medicine / Houston Veterans Adm Med Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.", 
        "overall_official": [
            {
                "last_name": "Cohn J", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Bilello J", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000818"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 1996"
    }, 
    "geocoordinates": {
        "AIDS Community Research Consortium": "37.485 -122.236", 
        "Baylor College of Medicine / Houston Veterans Adm Med Ctr": "29.76 -95.369", 
        "Cedars Sinai Med Ctr": "34.052 -118.244", 
        "Goodgame Med Group": "28.628 -81.363", 
        "Mount Zion Med Ctr / UCSF": "37.775 -122.419", 
        "North Broward Hosp District": "26.122 -80.143", 
        "Palo Alto Veterans Affairs Health Care System": "37.442 -122.143", 
        "Univ of Illinois": "41.878 -87.63", 
        "Univ of Texas Southwestern Med Ctr of Dallas": "32.803 -96.77"
    }
}